FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

5652011000001102: Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22816301000001116 Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22816401000001112 Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule Is pack of Dolasetron 12.5mg/0.625ml solution for injection ampoules false Inferred relationship Existential restriction modifier
Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule Has active ingredient Dolasetron mesilate false Inferred relationship Existential restriction modifier
Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule Has VMP Dolasetron 12.5mg/0.625ml solution for injection ampoules true Inferred relationship Existential restriction modifier
Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule Has specific active ingredient Dolasetron mesilate true Inferred relationship Existential restriction modifier
Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Anzemet I.V. 12.5mg/0.625ml solution for injection ampoules (Amdipharm) 10 ampoule 10 x 0.625ml ampoules Is a True Dolasetron 12.5mg/0.625ml solution for injection ampoules 10 ampoule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start